Cyclosporine and Intense Pulsed Light for Dry Eye in Contact Lens Users
Conditions: Dry Eye; Contact Lens Complication Interventions: Drug: CycloSPORINE Ophthalmic; Procedure: Intense Pulsed Light; Procedure: Sham Intense Pulse Light Sponsors: Universit é de Sherbrooke Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Anti-CD25 rhMAb in the Treatment of Steroid-Refractory cGVHD
Conditions: cGVHD Interventions: Drug: anti-CD25 rhMAb; Drug: Prednisone; Drug: Ruxolitinib; Drug: Cyclosporine Sponsors: Peking University People ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCT
Conditions: Ocular Graft-versus-host Disease Interventions: Drug: Cyclosporine ophthalmic solution 0.1%; Drug: Tacrolimus ophthalmic ointment 0.03% Sponsors: Hospital Universitario Dr. Jose E. Gonzalez Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
A Randomized Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With Cyclosporine
Conditions: Dry Eye Disease Interventions: Drug: Cyclosporine ophthalmic solution, 0.1% (VEVYE); Drug: Saline solution, 0.6% Sponsors: Novaliq GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With Cyclosporine
Conditions: Dry Eye Disease Interventions: Drug: Cyclosporine ophthalmic solution, 0.1% (VEVYE); Drug: Saline solution, 0.6% Sponsors: Novaliq GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Immunosuppressive Withdrawal After Pediatric Liver Transplantation
Conditions: Immune Tolerance; Immunosuppression; Liver Transplant; Complications Interventions: Drug: Tacrolimus or Cyclosporine A Sponsors: Wei Gao Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Conditions: Acute Leukemia of Ambiguous Lineage; Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Blastic Plasmacytoid Dendritic Cell Neoplasm; Hematopoietic and Lymphoid System Neoplasm; Mixed Phenotype Acute Leukemia; Myelodysplastic Syndrome; Myeloproliferati ve Neoplasm; Non-Hodgkin Lymphoma Interventions: Procedure: Biospecimen Collection; Procedure: Bone Marrow Aspirate; Drug: Cyclophosphamide; Drug: Cyclosporine; Procedure: Diagnostic Imaging; Procedure: Echocardiography; Drug: Fludarabine Phosphate; Procedure: Multigated Acq...
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials
